Fortress Biotech, Inc. (FBIO)
2.92
-0.02
(-0.68%)
USD |
NASDAQ |
Dec 12, 11:27
Fortress Biotech Gross Profit (Quarterly): 10.72M for Sept. 30, 2025
Gross Profit (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Quarterly) Benchmarks
| Journey Medical Corp. | 10.81M |
| Ultragenyx Pharmaceutical, Inc. | 123.34M |
| Axsome Therapeutics, Inc. | 156.67M |
| Apellis Pharmaceuticals, Inc. | 433.71M |
| Absci Corp. | -2.464M |